Evidence map›Paper›PMID 42162499›Full record

ArticleAMB Express2026

Odoribacter laneus protects intestinal barrier by bile acid-FXR axis in acute pancreatitis.

Ruru Gu, Jiazheng Li, Jinfeng Qi, Ruonan Sun, Honglei Wu, Bin Jin

Abstract read
In one paragraph

Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruru GuDepartment of Gastroenterology, The Second Qilu Hospital of Shandong University, Jinan, 250033, China.
Jiazheng LiDepartment of Hepatobiliary Surgery, The Second Qilu Hospital of Shandong University, Jinan, 250033, China.
Jinfeng QiDepartment of Gastroenterology, The Second Qilu Hospital of Shandong University, Jinan, 250033, China.
Ruonan SunDepartment of Gastroenterology, The Second Qilu Hospital of Shandong University, Jinan, 250033, China.
Honglei WuDepartment of Gastroenterology, The Second Qilu Hospital of Shandong University, Jinan, 250033, China. whl20011996@163.com.
Bin JinDepartment of Hepatobiliary Surgery, The Second Qilu Hospital of Shandong University, Jinan, 250033, China. jinbin@sdu.edu.cn.

Funding

the Cultivation Foundation of The Second Hospital of Shandong University 2023YP44
6 · The paper itself

Abstract

Odoribacter laneus (O. laneus) is a promising probiotic. Acute pancreatitis (AP) is an acute abodominal disease accompanied by intestinal barrier dysfunction and gut dysbiosis. However, the effects of O. laneus in AP remain unexplored. We established AP model of C57BL/6 mice. Western blotting and immunohistofluorescence were used to detect the expression of intestinal tight junction proteins and FXR/NLRP3 pathway. The changes of gut microbiota and bile acids (BAs) were analyzed by 16 S rRNA gene and targeted metabolomics sequencing. The fecal microbiota transplantation (FMT) was used to investigate the role of gut microbiota in O. laneus treatment. O. laneus effectively reduced systemic inflammation, pancreatic damage, and intestinal barrier dysfunction in AP mice. We observed significant enrichment of pathogens along with depletion of second BAs (7-KDA) in AP mice, and these alterations were reversed by O. laneus. FMT experiment showed that the protective roles of O. laneus depended on gut microbiota. O. laneus ameliorated AP via activating intestinal FXR and inhibiting NLRP3 inflammasome in vivo. In vitro and vivo studies showed that 7-KDA protected AP. Taken together, O. laneus could mitigate AP-induced intestinal barrier dysfunction by reversing the disorderd gut microbiota, BAs metabolism, and modulating FXR/NLRP3 pathway.

Indexed as

Acute pancreatitisBile acid metabolismFarnesoid X receptorIntestinal barrierOdoribacter laneus

Identifiers

PMID42162499
PMCPMC13365277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.